Cholecalciferol: A potent fat soluble vitamin to combat insomnia (A mini review)
Paper Details
Cholecalciferol: A potent fat soluble vitamin to combat insomnia (A mini review)
Abstract
The Significance of active form of vitamin D is much beyond its classical role in bone health. It performs different functions in the body and included in fat soluble class of vitamins. Insomnia is a sleeping disorder which affects the quality and quantity of sleep. Sleeping disorders are increasing tremendously among the developing countries. About one third population of Pakistan is suffering from chronic insomnia. The previous scientific data revealed that a significant relation persist between vitamin D deficiency, insomnia and inflammation resulted in low immunity health complications included; inflammatory bowel disease (IBD), rheumatoid arthritis, systemic lupus erythematous, multiple sclerosis (MS), atherosclerosis, or asthma. Furthermore, it has a potential role in the strengthening of the immune system and its associated health disorders that may increase the overall health care cost. Therefore, the aim of this article is to highlight the possible mechanism between the vitamin D in the betterment of sleep disorder and low immunity health risk factors.
Abbasi M, Hashemipour S, Hajmanuchehri F, Kazemifar AM. 2013. Is vitamin D deficiency associated with non-specific musculoskeletal pain? Global journal of health science 5(1), p.107.
Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. 1989. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. Journal of neurochemistry 52(5), pp.1655-1658.
Batool I, Afzal N, Khakwani M, Khan F. 2018. A Study of Cognitive Failures, Perceived Stress and Everyday Memory among Insomnia Patients. Isra Medical Journal 10(4), pp.207-211.
Bonnet MH, Arand DL. 2010. Hyperarousal and insomnia: state of the science. Sleep medicine reviews 14(1), pp.9-15.
Cass WA, Smith MP, Peters LE. 2006. Calcitriol protects against the dopamine‐and serotonin‐ depleting effects of neurotoxic doses of methamphetamine. Annals of the New York Academy of Sciences 1074(1), pp.261-271.
Chan HC, Ke LY, Chang LL, Liu CC, Hung YH, Lin CH, Li RN, Tsai WC, Liu HW, Yen JH. 2010. Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosus. Lupus 19(6), pp.696-702.
Connor JR, Wang XS, Allen RP, Beard JL, Wiesinger JA, Felt BT, Earley CJ. 2009. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 132(9), pp.2403-2412.
Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA. 2009. p38MAPK: stress responses from molecular mechanisms to therapeutics. Trends in molecular medicine 15(8), pp.369-379.
Da Silva AA, de Mello RGB, Schaan CW, Fuchs FD, Redline S, Fuchs SC. 2016. Sleep duration and mortality in the elderly: a systematic review with meta-analysis. BMJ open 6(2), p.e008119.
De Lourdes Samaniego-Vaesken M, Alonso-Aperte E, Varela-Moreiras G. 2012. Vitamin food fortification today. Food & nutrition research 56(1), p. 5459.
De Oliveira DL, Hirotsu C, Kim LJ, Tufik S, Andersen ML. 2018. 0875 Sleep Duration As An Independent Factor Associated With Vitamin D Levels In Episono Cohort. Sleep 41, p. A325.
De Oliveira DL, Hirotsu C, Tufik S, Andersen ML. 2017. The interfaces between vitamin D, sleep and pain. Journal of Endocrinology 234(1), pp.R23-R36.
Espie CA, Emsley R, Kyle SD, Gordon C, Drake CL, Siriwardena AN, Cape J, Ong JC, Sheaves B, Foster R, Freeman D. 2019. Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA psychiatry 76(1), pp. 21-30.
Finan PH, Smith MT. 2013. The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism. Sleep medicine reviews 17(3), pp. 173-183.
Finan PH, Goodin BR, Smith MT. 2013. The association of sleep and pain: an update and a path forward. The Journal of Pain 14(12), pp.1539-1552.
Ganji V, Milone C, Cody MM, McCarty F, Wang YT. 2010. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. International Archives of Medicine 3(1), p.29.
Gao Q, Kou T, Zhuang B, Ren Y, Dong X, Wang Q. 2018. The Association between vitamin D deficiency and sleep disorders: A systematic review and meta-analysis. Nutrients 10(10), p.1395.
Gominak SC, Stumpf WE. 2012. The world epidemic of sleep disorders is linked to vitamin D deficiency. Medical hypotheses 79(2), pp.132-135.
Högberg G, Gustafsson SA, Hällström T, Gustafsson T, Klawitter B, Petersson M. 2012. Depressed adolescents in a case‐series were low in vitamin D and depression was ameliorated by vitamin D supplementation. ActaPaediatrica 101(7), pp.779-783.
Holick MF. 2012. Evidence-based D-bate on health benefits of vitamin D revisited. Dermato-endocrinology 4(2), pp.183-190.
Horvitz JC. 2002. Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behavioural brain research 137(1-2), pp.65-74.
Huang W, Shah S, Long Q, Crankshaw AK, Tangpricha V. 2013. Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation. The Clinical journal of pain 29(4), pp.341-347.
Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 2011. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57(1), pp.63-69.
Kato S. 2000. The function of vitamin D receptor in vitamin D action. The Journal of Biochemistry 127(5), pp.717-722.
Kidwai R, Ahmed SH. 2013. Prevalence of insomnia and use of sleep medicines in urban communities of Karachi, Pakistan. Journal of the Pakistan Medical Association 63(11), pp.1358-1363.
Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, Modlin RL. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. The Journal of Immunology 181(10), pp.7115-7120.
Majid MS, Ahmad HS, Bizhan H, Hosein HZM, Mohammad A. 2018. The effect of vitamin D supplement on the score and quality of sleep in 20–50 year-old people with sleep disorders compared with control group. Nutritional neuroscience 21(7), pp.511-519.
Massa J, Stone KL, Wei EK, Harrison SL, Barrett-Connor E, Lane NE, Paudel M, Redline S, Ancoli-Israel S, Orwoll E, Schernhammer E. 2015. Vitamin D and actigraphic sleep outcomes in older community-dwelling men: the MrOS sleep study. Sleep 38(2), pp.251-257.
McCarty DE, Reddy A, Keigley Q, Kim PY, Marino AA. 2012. Vitamin D, race, and excessive daytime sleepiness. Journal of Clinical Sleep Medicine 8(06), pp.693-697.
Okura K, Lavigne GJ, Huynh N, Manzini C, Fillipini D, Montplaisir JY. 2008. Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice. Sleep medicine 9(4), pp.352-361.
Riaz H, Finlayson AE, Bashir S, Hussain S, Mahmood S, Malik F, Godman B. 2016. Prevalence of Vitamin D deficiency in Pakistan and implications for the future. Expert review of clinical pharmacology 9(2), pp.329-338.
Sahakyan G. 2018. The role of Vitamin D in treatment of Chronic Insomnia with Melatonin (P5. 320).
Seyedi M, Gholami F, Samadi M, Djalali M, Effatpanah M, Yekaninejad MS, Hashemi R, Abdolahi M, Chamari M, Honarvar NM. 2019. The Effect of Vitamin D3 Supplementation on Serum BDNF, Dopamine, and Serotonin in Children with Attention-Deficit/Hyperactivity Disorder. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 18(6), pp.496-501.
Smith MP, Fletcher-Turner A, Yurek DM, Cass WA. 2006. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochemical research 31(4), pp.533-539.
Smith MT, Perlis ML, Chengazi VU, Pennington J, Soeffing J, Ryan JM, Giles DE. 2002. Neuroimaging of NREM sleep in primary insomnia: a Tc-99-HMPAO single photon emission computed tomography study. Sleep 25(3), pp.325-335.
Smith MT, Perlis ML, Chengazi VU, Pennington J, Soeffing J, Ryan JM, Giles DE. 2002. Neuroimaging of NREM sleep in primary insomnia: a Tc-99-HMPAO single photon emission computed tomography study. Sleep 25(3), pp.325-335.
Taylor DJ, Lichstein KL, Durrence HH, Reidel BW, Bush AJ. 2005. Epidemiology of insomnia, depression, and anxiety. Sleep 28(11), pp.1457-1464.
Toujani S, Kaabachi W, Mjid M, Hamzaoui K, Cherif J, Beji M. 2017. Vitamin D deficiency and interleukin-17 relationship in severe obstructive sleep apnea–hypopnea syndrome. Annals of thoracic medicine 12(2), p.107.
vanEtten E, Mathieu C. 2005. Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. The Journal of steroid biochemistry and molecular biology 97(1-2), pp.93-101.
Zarubin T, Jiahuai HAN. 2005. Activation and signaling of the p38 MAP kinase pathway. Cell research 15(1), pp.11-18.
Shahnai Basharat, Aiman Ijaz, Fatima Abid, Faiza Iftikhar, Syed Amir Gilani (2020), Cholecalciferol: A potent fat soluble vitamin to combat insomnia (A mini review); IJB, V16, N4, April, P462-469
https://innspub.net/cholecalciferol-a-potent-fat-soluble-vitamin-to-combat-insomnia-a-mini-review/
Copyright © 2020
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0